EditorialCreativeSportsCollectionsVideos
Prices
0Log in

Visual content for professionals.
800M+ images and videos.

Content Hub

  • Current Events
  • Pictures of the Year
  • Sports
  • Editorial
  • Creative
  • Collections
  • Videos

Offers

  • Prices & Packages
  • Promotions
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Content Research
  • Contract Photography
  • API & FTP Push
  • my-picturemaxx
  • Become a Partner

Company

  • About IMAGO
  • Careers
  • News

Help Center

  • FAQ
  • Contact Us
Legal NoticeTerms & ConditionsLicense InformationData PrivacyPrivacy Settings
© 2026 IMAGO
CEPICBAPLABVPA
  1. Coronavirus: AstraZeneca hopes to receive vaccine approval in 2020

Coronavirus: AstraZeneca hopes to receive vaccine approval in 2020

Aug 25, 2020

The following photos have been selected for you by the IMAGO picture desk on this topic. For more pictures please use the search function.

Images in this collection

  • ASTRAZENECA STOCK, A general view of analytical chemist?s at AstraZeneca?s headquarters in Sydney, Wednesday, August 19, 2020. Prime Minister Scott Morrison announced Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the government and UK-based drug company AstraZeneca. ( NO ARCHIVING, EDITORIAL USE ONLY, NO USE IN BOOKS WITHOUT CONSENT Sydney NSW AUSTRALIA  Copyright: xDANxHIMBRECHTSx 20200819001485708630

    ASTRAZENECA STOCK, A general view of analytical chemist?s at AstraZeneca?s headquarters in Sydney, Wednesday, August 19, 2020. Prime Minister Scott Morrison announced Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the government and UK-based drug company AstraZeneca. ( NO ARCHIVING, EDITORIAL USE ONLY, NO USE IN BOOKS WITHOUT CONSENT Sydney NSW AUSTRALIA Copyright: xDANxHIMBRECHTSx 20200819001485708630

  • ASTRAZENECA STOCK, A general view of AstraZeneca?s headquarters in Sydney, Wednesday, August 19, 2020. Prime Minister Scott Morrison announced Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the government and UK-based drug company AstraZeneca. ( NO ARCHIVING, EDITORIAL USE ONLY, NO USE IN BOOKS WITHOUT CONSENT Sydney NSW AUSTRALIA  Copyright: xDANxHIMBRECHTSx 20200819001485708584

    ASTRAZENECA STOCK, A general view of AstraZeneca?s headquarters in Sydney, Wednesday, August 19, 2020. Prime Minister Scott Morrison announced Australians will be among the first in the world to receive a COVID-19 vaccine, if it proves successful, through an agreement between the government and UK-based drug company AstraZeneca. ( NO ARCHIVING, EDITORIAL USE ONLY, NO USE IN BOOKS WITHOUT CONSENT Sydney NSW AUSTRALIA Copyright: xDANxHIMBRECHTSx 20200819001485708584

  • Symbol image of a corona vaccine with the logo of the pharmaceutical company AstraZeneca Researchers at Oxford University seem to have succeeded in taking a big step towards a corona vaccine Foto:xJ.xKrickx xFuturexImage

    Symbol image of a corona vaccine with the logo of the pharmaceutical company AstraZeneca Researchers at Oxford University seem to have succeeded in taking a big step towards a corona vaccine Foto:xJ.xKrickx xFuturexImage

  • Symbol image of a corona vaccine with the logo of the pharmaceutical company AstraZeneca Researchers at Oxford University seem to have succeeded in taking a big step towards a corona vaccine Foto:xJ.xKrickx xFuturexImage

    Symbol image of a corona vaccine with the logo of the pharmaceutical company AstraZeneca Researchers at Oxford University seem to have succeeded in taking a big step towards a corona vaccine Foto:xJ.xKrickx xFuturexImage

  • NIJMEGEN: 18-06-2020, Company Astrazeneca in Nijmegen (The Netherlands), Astra Zeneca COVID-19: Company Astrazeneca in Nijmegen  x8446244x Copyright:

    NIJMEGEN: 18-06-2020, Company Astrazeneca in Nijmegen (The Netherlands), Astra Zeneca COVID-19: Company Astrazeneca in Nijmegen x8446244x Copyright:

  • NIJMEGEN: 18-06-2020, Company Astrazeneca in Nijmegen (The Netherlands), Astra Zeneca COVID-19: Company Astrazeneca in Nijmegen  x8446243x Copyright:

    NIJMEGEN: 18-06-2020, Company Astrazeneca in Nijmegen (The Netherlands), Astra Zeneca COVID-19: Company Astrazeneca in Nijmegen x8446243x Copyright:

  • (200519) -- BEIJING, May 19, 2020 -- Photo taken on May 18, 2020 shows a logo in front of AstraZeneca s building in Luton, Britain. The Oxford University has confirmed a global licensing agreement with AstraZeneca, which will make 30 million vaccine doses available to Britain by September if the trials are successful, as part of an agreement for 100 million doses in total, said British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma. (Photo by Xinhua) XINHUA PHOTOS OF THE DAY TimxIreland

    (200519) -- BEIJING, May 19, 2020 -- Photo taken on May 18, 2020 shows a logo in front of AstraZeneca s building in Luton, Britain. The Oxford University has confirmed a global licensing agreement with AstraZeneca, which will make 30 million vaccine doses available to Britain by September if the trials are successful, as part of an agreement for 100 million doses in total, said British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma. (Photo by Xinhua) XINHUA PHOTOS OF THE DAY TimxIreland

  • (200518) -- LUTON, May 18, 2020 (Xinhua) -- Photo taken on May 18, 2020 shows a logo in front of AstraZeneca s building in Luton, Britain. The Oxford University has confirmed a global licensing agreement with AstraZeneca, which will make 30 million vaccine doses available to Britain by September if the trials are successful, as part of an agreement for 100 million doses in total, said British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma. (Photo by Tim Ireland Xinhua) BRITAIN-LUTON-COVID-19-VACCINE

    (200518) -- LUTON, May 18, 2020 (Xinhua) -- Photo taken on May 18, 2020 shows a logo in front of AstraZeneca s building in Luton, Britain. The Oxford University has confirmed a global licensing agreement with AstraZeneca, which will make 30 million vaccine doses available to Britain by September if the trials are successful, as part of an agreement for 100 million doses in total, said British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma. (Photo by Tim Ireland Xinhua) BRITAIN-LUTON-COVID-19-VACCINE

  • ST PETERSBURG, RUSSIA – JUNE 7, 2019: AstraZeneca CEO Pascal Soriot at the 2019 St Petersburg International Economic Forum (SPIEF), at the ExpoForum Convention and Exhibition Centre. Anton Novoderezhkin TASS Host Photo Agency  TS0AE59F

    ST PETERSBURG, RUSSIA – JUNE 7, 2019: AstraZeneca CEO Pascal Soriot at the 2019 St Petersburg International Economic Forum (SPIEF), at the ExpoForum Convention and Exhibition Centre. Anton Novoderezhkin TASS Host Photo Agency TS0AE59F

  • April 29, 2019 - GloRia De Dourados, Mato Grosso do Sul, Brazil - In this photo illustration the AstraZeneca PLC logo seen displayed on a smartphone. GloRia De Dourados Brazil - ZUMAs197 20190429_zab_s197_025 Copyright: xRafaelxHenriquex

    April 29, 2019 - GloRia De Dourados, Mato Grosso do Sul, Brazil - In this photo illustration the AstraZeneca PLC logo seen displayed on a smartphone. GloRia De Dourados Brazil - ZUMAs197 20190429_zab_s197_025 Copyright: xRafaelxHenriquex

  • February 26, 2019 - Washington, District of Columbia, U.S. - Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: CNP Washington U.S. - ZUMAs152 20190226_zaa_s152_044 Copyright: xChrisxKleponisx

    February 26, 2019 - Washington, District of Columbia, U.S. - Pascal Soriot, Executive Director and Chief Executive Officer, AstraZeneca appears before the Senate Committee on Finance for a hearing on prescription drug pricing on Capitol Hill in Washington, DC, February 26, 2019. Credit: CNP Washington U.S. - ZUMAs152 20190226_zaa_s152_044 Copyright: xChrisxKleponisx

  • Pascal Soriot, executive director and CEO of AstraZeneca looks on during a Senate Finance Committee hearing on Drug Pricing in America on Capitol Hill in Washington, D.C. on February 26, 2019.  WAP201902268029 ALEXxEDELMAN

    Pascal Soriot, executive director and CEO of AstraZeneca looks on during a Senate Finance Committee hearing on Drug Pricing in America on Capitol Hill in Washington, D.C. on February 26, 2019. WAP201902268029 ALEXxEDELMAN

Collections